Core Scientific Inc (NASDAQ: CORZ): To Buy Or Not To Buy, That Is The Question

Core Scientific Inc (CORZ) concluded trading on Thursday at a closing price of $3.60, with 3.7 million shares of worth about $13.33 million changed hands on the day. On Thursday the price saw a gain of about 4.96%. Currently the company’s common shares owned by public are about 388.26M shares, out of which, 383.37M shares are available for trading.

Over the period of past 52 weeks, stock dropped to lowest price of $2.61 but also hit the highest price of $6.10 during that period. The average intraday trading volume for Core Scientific Inc shares is 2.48 million. The stock is currently trading 12.69% above its 20-day simple moving average (SMA20), while that difference is up 12.69% for SMA50 and it goes to 12.69% higher than SMA200.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock has a current market capitalization of $1.40B. It has posted earnings per share of -$1.32 in the same period. It has Quick Ratio of 0.43. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CORZ, volatility over the week remained 10.56%.

Analysts are in expectations that Core Scientific Inc (CORZ) stock would likely to be making an EPS of -$0.15 in the current quarter, while forecast for next quarter EPS is -$0.08 and it is -$0.25 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.17 which is -$0.13 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.41 in the same quarter a year ago.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Compass Point on January 31, 2024 offering a Buy rating for the stock and assigned a target price range of between $1 and $8.50 to it.

Most Popular

Related Posts